{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:26:13Z","timestamp":1791217573399,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Identification of novel molecular signaling targets for non-small cell lung cancer (NSCLC) is important. The present study examined expression, functions and possible underlying mechanisms of the sodium\/myo-inositol co-transporter SLC5A3 in NSCLC. The Cancer Genome Atlas (TCGA) database and local NSCLC tissue results demonstrated that SLC5A3 expression in NSCLC tissues (including patient-derived primary NSCLC cells) was significantly higher than that in normal lung tissues and lung epithelial cells. In primary NSCLC cells and immortalized lines, SLC5A3 depletion, using small hairpin RNA (shRNA) and CRSIRP\/Cas9 methods, robustly impeded cell proliferation and migration, simultaneously provoking cell cycle arrest and apoptosis. Conversely, ectopic overexpression of SLC5A3 further enhanced proliferation and migration in primary NSCLC cells. The intracellular myo-inositol contents and Akt-mTOR activation were largely inhibited by SLC5A3 silencing or knockout (KO), but were augmented following SLC5A3 overexpression in primary NSCLC cells. Significantly, SLC5A3 KO-induced anti-NSCLC cell activity was largely ameliorated by exogenously adding myo-inositol or by a constitutively-active Akt construct. By employing the patient-derived xenograft (PDX) model, we found that the growth of subcutaneous NSCLC xenografts in nude mice was largely inhibited by intratumoral injection SLC5A3 shRNA adeno-associated virus (AAV). SLC5A3 silencing, myo-inositol depletion, Akt-mTOR inactivation and apoptosis induction were detected in SLC5A3 shRNA virus-injected NSCLC xenograft tissues. Together, elevated SLC5A3 promotes NSCLC cell growth possibly by maintaining myo-inositol contents and promoting Akt-mTOR activation.<\/jats:p>","DOI":"10.1038\/s41419-022-05017-y","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T07:02:44Z","timestamp":1656313364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The sodium\/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth"],"prefix":"10.1038","volume":"13","author":[{"given":"Zihan","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyong","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9369-8916","authenticated-orcid":false,"given":"Zhi-qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8903-8205","authenticated-orcid":false,"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8312-2481","authenticated-orcid":false,"given":"Chun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"5017_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet 2021;398:535\u201354.","journal-title":"Lancet"},{"key":"5017_CR2","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0140-6736(16)31340-X","volume":"388","author":"CT Hiley","year":"2016","unstructured":"Hiley CT, Le Quesne J, Santis G, Sharpe R, de Castro DG, Middleton G, et al. Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease. Lancet. 2016;388:1002\u201311.","journal-title":"Lancet"},{"key":"5017_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin."},{"key":"5017_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"5017_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","volume":"19","author":"F Skoulidis","year":"2019","unstructured":"Skoulidis F, Heymach JV. Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy. Nat Rev Cancer. 2019;19:495\u2013509.","journal-title":"Nat Rev Cancer"},{"key":"5017_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/0284186X.2017.1404634","volume":"57","author":"HH Vestergaard","year":"2018","unstructured":"Vestergaard HH, Christensen MR, Lassen UN. A systematic review of targeted agents for non-small cell lung cancer. Acta Oncol. 2018;57:176\u201386.","journal-title":"Acta Oncol"},{"key":"5017_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1158\/2159-8290.CD-20-1849","volume":"12","author":"Y Wei","year":"2022","unstructured":"Wei Y, Huang YH, Skopelitis DS, Iyer SV, Costa ASH, Yang Z, et al. SLC5A3-dependent myo-inositol auxotrophy in acute myeloid leukemia. Cancer Discov. 2022;12:450\u2013467.","journal-title":"Cancer Discov"},{"key":"5017_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1006\/geno.1997.5055","volume":"46","author":"JJ Mallee","year":"1997","unstructured":"Mallee JJ, Atta MG, Lorica V, Rim JS, Kwon HM, Lucente AD, et al. The structural organization of the human Na+\/myo-inositol cotransporter (SLC5A3) gene and characterization of the promoter. Genomics 1997;46:459\u201365.","journal-title":"Genomics"},{"key":"5017_CR9","doi-asserted-by":"publisher","first-page":"521.","DOI":"10.3390\/biom10040521","volume":"10","author":"B De Paepe","year":"2020","unstructured":"De Paepe B, Merckx C, Jarosova J, Cannizzaro M, De Bleecker JL. Myo-Inositol Transporter SLC5A3 Associates with Degenerative Changes and Inflammation in Sporadic Inclusion Body Myositis. Biomolecules. 2020;10:521.","journal-title":"Biomolecules"},{"key":"5017_CR10","doi-asserted-by":"publisher","first-page":"e0119990","DOI":"10.1371\/journal.pone.0119990","volume":"10","author":"J Andronic","year":"2015","unstructured":"Andronic J, Shirakashi R, Pickel SU, Westerling KM, Klein T, Holm T, et al. Hypotonic activation of the myo-inositol transporter SLC5A3 in HEK293 cells probed by cell volumetry, confocal and super-resolution microscopy. PLoS ONE. 2015;10:e0119990.","journal-title":"PLoS ONE"},{"key":"5017_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04164-y","volume":"12","author":"C Zhang","year":"2021","unstructured":"Zhang C, Niu Y, Wang Z, Xu X, Li Y, Ma L, et al. Corosolic acid inhibits cancer progression by decreasing the level of CDK19-mediated O-GlcNAcylation in liver cancer cells. Cell Death Dis. 2021;12:889.","journal-title":"Cell Death Dis"},{"key":"5017_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04039-2","volume":"12","author":"T Zhou","year":"2021","unstructured":"Zhou T, Sang YH, Cai S, Xu C, Shi MH. The requirement of mitochondrial RNA polymerase for non-small cell lung cancer cell growth. Cell Death Dis. 2021;12:751.","journal-title":"Cell Death Dis"},{"key":"5017_CR13","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.21037\/tlcr-21-767","volume":"10","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Cui Z, Xie Z, Li C, Xu C, Guo X, et al. Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1. Transl Lung Cancer Res. 2021;10:3995\u20134011.","journal-title":"Transl Lung Cancer Res."},{"key":"5017_CR14","doi-asserted-by":"publisher","first-page":"936","DOI":"10.21037\/tlcr-21-147","volume":"10","author":"Q Li","year":"2021","unstructured":"Li Q, Yu D, Yu Z, Gao Q, Chen R, Zhou L, et al. TIPE3 promotes non-small cell lung cancer progression via the protein kinase B\/extracellular signal-regulated kinase 1\/2-glycogen synthase kinase 3beta-beta-catenin\/Snail axis. Transl Lung Cancer Res. 2021;10:936\u201354.","journal-title":"Transl Lung Cancer Res"},{"key":"5017_CR15","doi-asserted-by":"publisher","first-page":"8535","DOI":"10.7150\/thno.61452","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Liu YY, Chen MB, Cheng KW, Qi LN, Zhang ZQ, et al. Neuronal-driven glioma growth requires Galphai1 and Galphai3. Theranostics 2021;11:8535\u201349.","journal-title":"Theranostics"},{"key":"5017_CR16","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1038\/s41388-018-0184-5","volume":"37","author":"YY Liu","year":"2018","unstructured":"Liu YY, Chen MB, Cheng L, Zhang ZQ, Yu ZQ, Jiang Q, et al. microRNA-200a downregulation in human glioma leads to Galphai1 over-expression, Akt activation, and cell proliferation. Oncogene 2018;37:2890\u2013902.","journal-title":"Oncogene"},{"key":"5017_CR17","doi-asserted-by":"publisher","first-page":"691602","DOI":"10.3389\/fmolb.2021.691602","volume":"8","author":"X Lu","year":"2021","unstructured":"Lu X, Fan Y, Li M, Chang X, Qian J. HTR2B and SLC5A3 Are Specific Markers in Age-Related Osteoarthritis and Involved in Apoptosis and Inflammation of Osteoarthritis Synovial Cells. Front Mol Biosci. 2021;8:691602.","journal-title":"Front Mol Biosci"},{"key":"5017_CR18","doi-asserted-by":"publisher","first-page":"669518","DOI":"10.3389\/fonc.2021.669518","volume":"11","author":"JH Zha","year":"2021","unstructured":"Zha JH, Xia YC, Ye CL, Hu Z, Zhang Q, Xiao H, et al. The Anti-Non-Small Cell Lung Cancer Cell Activity by a mTOR Kinase Inhibitor PQR620. Front Oncol. 2021;11:669518.","journal-title":"Front Oncol"},{"key":"5017_CR19","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1073\/pnas.1733027100","volume":"100","author":"A Diez-Sampedro","year":"2003","unstructured":"Diez-Sampedro A, Hirayama BA, Osswald C, Gorboulev V, Baumgarten K, Volk C, et al. A glucose sensor hiding in a family of transporters. Proc Natl Acad Sci USA. 2003;100:11753\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5017_CR20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41419-021-04039-2","volume":"12","author":"T Zhou","year":"2021","unstructured":"Zhou T, Sang Y-H, Cai S, Xu C, Shi M-H. The requirement of mitochondrial RNA polymerase for non-small cell lung cancer cell growth. Cell Death Dis. 2021;12:751.","journal-title":"Cell Death Dis"},{"key":"5017_CR21","doi-asserted-by":"publisher","first-page":"R222","DOI":"10.1152\/ajpregu.00304.2018","volume":"316","author":"M Subramaniam","year":"2019","unstructured":"Subramaniam M, Weber LP, Loewen ME. Intestinal electrogenic sodium-dependent glucose absorption in tilapia and trout reveal species differences in SLC5A-associated kinetic segmental segregation. Am J Physiol Regul Integr Comp Physiol. 2019;316:R222\u2013R234.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"5017_CR22","doi-asserted-by":"publisher","first-page":"C431","DOI":"10.1152\/ajpcell.00054.2014","volume":"307","author":"LJ Sasseville","year":"2014","unstructured":"Sasseville LJ, Longpre JP, Wallendorff B, Lapointe JY. The transport mechanism of the human sodium\/myo-inositol transporter 2 (SMIT2\/SGLT6), a member of the LeuT structural family. Am J Physiol Cell Physiol. 2014;307:C431\u2013441.","journal-title":"Am J Physiol Cell Physiol"},{"key":"5017_CR23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1158\/2159-8290.CD-20-1849","volume":"12","author":"Y Wei","year":"2022","unstructured":"Wei Y, Huang YH, Skopelitis DS, Iyer SV, Costa ASH, Yang Z, et al. SLC5A3-Dependent Myo-inositol Auxotrophy in Acute Myeloid Leukemia. Cancer Disco. 2022;12:450\u201367.","journal-title":"Cancer Disco"},{"key":"5017_CR24","first-page":"200","volume":"5","author":"MP Vawter","year":"2019","unstructured":"Vawter MP, Hamzeh AR, Muradyan E, Civelli O, Abbott GW, Alachkar A. Association of Myoinositol Transporters with Schizophrenia and Bipolar Disorder: Evidence from Human and Animal Studies. Mol Neuropsychiatry. 2019;5:200\u201311.","journal-title":"Mol Neuropsychiatry"},{"key":"5017_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preghy.2017.07.001","volume":"10","author":"R D\u2019Oria","year":"2017","unstructured":"D\u2019Oria R, Laviola L, Giorgino F, Unfer V, Bettocchi S, Scioscia M. PKB\/Akt and MAPK\/ERK phosphorylation is highly induced by inositols: Novel potential insights in endothelial dysfunction in preeclampsia. Pregnancy Hypertens. 2017;10:107\u201312.","journal-title":"Pregnancy Hypertens"},{"key":"5017_CR26","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.2217\/pgs.15.122","volume":"16","author":"C Perez-Ramirez","year":"2015","unstructured":"Perez-Ramirez C, Canadas-Garre M, Molina MA, Faus-Dader MJ, Calleja-Hernandez MA. PTEN and PI3K\/AKT in non-small-cell lung cancer. Pharmacogenomics 2015;16:1843\u201362.","journal-title":"Pharmacogenomics"},{"key":"5017_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ctrv.2013.08.006","volume":"40","author":"S Heavey","year":"2014","unstructured":"Heavey S, O\u2019Byrne KJ, Gately K. Strategies for co-targeting the PI3K\/AKT\/mTOR pathway in NSCLC. Cancer Treat Rev. 2014;40:445\u201356.","journal-title":"Cancer Treat Rev"},{"key":"5017_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bcp.2014.05.011","volume":"90","author":"C Fumarola","year":"2014","unstructured":"Fumarola C, Bonelli MA, Petronini PG, Alfieri RR. Targeting PI3K\/AKT\/mTOR pathway in non small cell lung cancer. Biochem Pharm. 2014;90:197\u2013207.","journal-title":"Biochem Pharm"},{"key":"5017_CR29","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr., Kinzler KW. Cancer genome landscapes. Science 2013;339:1546\u201358.","journal-title":"Science"},{"key":"5017_CR30","doi-asserted-by":"publisher","first-page":"9824","DOI":"10.1158\/0008-5472.CAN-05-1543","volume":"65","author":"SD Kendall","year":"2005","unstructured":"Kendall SD, Linardic CM, Adam SJ, Counter CM. A network of genetic events sufficient to convert normal human cells to a tumorigenic state. Cancer Res. 2005;65:9824\u20138.","journal-title":"Cancer Res"},{"key":"5017_CR31","doi-asserted-by":"publisher","first-page":"9027","DOI":"10.1158\/0008-5472.CAN-04-3703","volume":"64","author":"RD Ramirez","year":"2004","unstructured":"Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, Pollack J, et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res. 2004;64:9027\u201334.","journal-title":"Cancer Res"},{"key":"5017_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/path.5038","volume":"244","author":"JN Gallant","year":"2018","unstructured":"Gallant JN, Lovly CM. Established, emerging and elusive molecular targets in the treatment of lung cancer. J Pathol. 2018;244:565\u201377.","journal-title":"J Pathol"},{"key":"5017_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1073\/pnas.1421839112","volume":"112","author":"C Tomasetti","year":"2015","unstructured":"Tomasetti C, Marchionni L, Nowak MA, Parmigiani G, Vogelstein B. Only three driver gene mutations are required for the development of lung and colorectal cancers. Proc Natl Acad Sci USA. 2015;112:118\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5017_CR34","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1158\/0008-5472.CAN-05-2521","volume":"66","author":"M Sato","year":"2006","unstructured":"Sato M, Vaughan MB, Girard L, Peyton M, Lee W, Shames DS, et al. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res. 2006;66:2116\u201328.","journal-title":"Cancer Res"},{"key":"5017_CR35","doi-asserted-by":"publisher","first-page":"757323","DOI":"10.3389\/fonc.2021.757323","volume":"11","author":"KR Cargill","year":"2021","unstructured":"Cargill KR, Hasken WL, Gay CM, Byers LA. Alternative Energy: Breaking Down the Diverse Metabolic Features of Lung Cancers. Front Oncol. 2021;11:757323.","journal-title":"Front Oncol"},{"key":"5017_CR36","doi-asserted-by":"publisher","first-page":"578315","DOI":"10.3389\/fonc.2020.578315","volume":"10","author":"J Zhao","year":"2020","unstructured":"Zhao J, Lin X, Meng D, Zeng L, Zhuang R, Huang S, et al. Nrf2 Mediates Metabolic Reprogramming in Non-Small Cell Lung Cancer. Front Oncol. 2020;10:578315.","journal-title":"Front Oncol"},{"key":"5017_CR37","doi-asserted-by":"publisher","first-page":"188462","DOI":"10.1016\/j.bbcan.2020.188462","volume":"1875","author":"CM Dowling","year":"2021","unstructured":"Dowling CM, Zhang H, Chonghaile TN, Wong KK. Shining a light on metabolic vulnerabilities in non-small cell lung cancer. Biochim Biophys Acta Rev Cancer. 2021;1875:188462.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"5017_CR38","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1038\/s41388-018-0307-z","volume":"37","author":"X Ji","year":"2018","unstructured":"Ji X, Qian J, Rahman SMJ, Siska PJ, Zou Y, Harris BK, et al. xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression. Oncogene 2018;37:5007\u201319.","journal-title":"Oncogene"},{"key":"5017_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/1759-7714.13328","volume":"11","author":"AC Tan","year":"2020","unstructured":"Tan AC. Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC). Thorac Cancer. 2020;11:511\u20138.","journal-title":"Thorac Cancer"},{"key":"5017_CR40","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/JTO.0b013e3181ce6604","volume":"5","author":"T Dhillon","year":"2010","unstructured":"Dhillon T, Mauri FA, Bellezza G, Cagini L, Barbareschi M, North BV, et al. Overexpression of the mammalian target of rapamycin: a novel biomarker for poor survival in resected early stage non-small cell lung cancer. J Thorac Oncol. 2010;5:314\u20139.","journal-title":"J Thorac Oncol"},{"key":"5017_CR41","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.biopha.2017.07.005","volume":"93","author":"X Zhang","year":"2017","unstructured":"Zhang X, He X, Liu Y, Zhang H, Chen H, Guo S, et al. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K\/AKT signal pathway by targeting MALAT-1. Biomed Pharmacother. 2017;93:1065\u201373.","journal-title":"Biomed Pharmacother"},{"key":"5017_CR42","doi-asserted-by":"publisher","first-page":"28935","DOI":"10.18632\/oncotarget.7898","volume":"7","author":"G Zhang","year":"2016","unstructured":"Zhang G, Wang C, Sun M, Li J, Wang B, Jin C, et al. Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells. Oncotarget 2016;7:28935\u201346.","journal-title":"Oncotarget"},{"key":"5017_CR43","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/ijc.23371","volume":"122","author":"MW Lee","year":"2008","unstructured":"Lee MW, Kim DS, Min NY, Kim HT. Akt1 inhibition by RNA interference sensitizes human non-small cell lung cancer cells to cisplatin. Int J Cancer. 2008;122:2380\u20134.","journal-title":"Int J Cancer"},{"key":"5017_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2019.01.042","volume":"448","author":"D Huang","year":"2019","unstructured":"Huang D, Cao L, Xiao L, Song JX, Zhang YJ, Zheng P, et al. Hypoxia induces actin cytoskeleton remodeling by regulating the binding of CAPZA1 to F-actin via PIP2 to drive EMT in hepatocellular carcinoma. Cancer Lett. 2019;448:117\u201327.","journal-title":"Cancer Lett"},{"key":"5017_CR45","doi-asserted-by":"publisher","first-page":"409","DOI":"10.4161\/cam.21192","volume":"6","author":"N Thapa","year":"2012","unstructured":"Thapa N, Anderson RA. PIP2 signaling, an integrator of cell polarity and vesicle trafficking in directionally migrating cells. Cell Adh Migr. 2012;6:409\u201312.","journal-title":"Cell Adh Migr"},{"key":"5017_CR46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.15252\/embr.201642681","volume":"18","author":"AW Hong","year":"2017","unstructured":"Hong AW, Meng Z, Yuan HX, Plouffe SW, Moon S, Kim W, et al. Osmotic stress-induced phosphorylation by NLK at Ser128 activates YAP. EMBO Rep. 2017;18:72\u201386.","journal-title":"EMBO Rep."},{"key":"5017_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/nar\/gks988","volume":"41","author":"C Cagliero","year":"2013","unstructured":"Cagliero C, Jin DJ. Dissociation and re-association of RNA polymerase with DNA during osmotic stress response in Escherichia coli. Nucleic Acids Res. 2013;41:315\u201326.","journal-title":"Nucleic Acids Res"},{"key":"5017_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.molcel.2007.01.005","volume":"25","author":"Y Xia","year":"2007","unstructured":"Xia Y, Wang J, Liu TJ, Yung WK, Hunter T, Lu Z. c-Jun downregulation by HDAC3-dependent transcriptional repression promotes osmotic stress-induced cell apoptosis. Mol Cell. 2007;25:219\u201332.","journal-title":"Mol Cell"},{"key":"5017_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50198-w","volume":"9","author":"A Miermont","year":"2019","unstructured":"Miermont A, Lee SWL, Adriani G, Kamm RD. Quantitative screening of the effects of hyper-osmotic stress on cancer cells cultured in 2- or 3-dimensional settings. Sci Rep. 2019;9:13782.","journal-title":"Sci Rep"},{"key":"5017_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95740-x","volume":"11","author":"D Mohammed","year":"2021","unstructured":"Mohammed D, Park CY, Fredberg JJ, Weitz DA. Tumorigenic mesenchymal clusters are less sensitive to moderate osmotic stresses due to low amounts of junctional E-cadherin. Sci Rep. 2021;11:16279.","journal-title":"Sci Rep."},{"key":"5017_CR51","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1111\/cas.14079","volume":"110","author":"K Morishita","year":"2019","unstructured":"Morishita K, Watanabe K, Ichijo H. Cell volume regulation in cancer cell migration driven by osmotic water flow. Cancer Sci. 2019;110:2337\u201347.","journal-title":"Cancer Sci"},{"key":"5017_CR52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cellsig.2017.07.021","volume":"39","author":"NA Blessing","year":"2017","unstructured":"Blessing NA, Kasturirangan S, Zink EM, Schroyer AL, Chadee DN. Osmotic and heat stress-dependent regulation of MLK4beta and MLK3 by the CHIP E3 ligase in ovarian cancer cells. Cell Signal. 2017;39:66\u201373.","journal-title":"Cell Signal"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05017-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05017-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05017-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:02:40Z","timestamp":1669302160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05017-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["5017"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05017-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"10 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by Ethics Committee of The First Affiliated Hospital of Zhengzhou University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"569"}}